Liquidity & Technical

Figures converted from HKD (trading currency) at HK$7.80/$1 (the HKD peg). Ratios, margins, multiples, share counts, percentages, RSI, and volatility values are unitless and unchanged.

Liquidity & Technical Read

Liquidity is emphatically not the gating constraint: $114M of daily traded value supports a 5% position for funds up to $2.03B at 20% participation over five sessions, and a 1% issuer-level stake can be built or unwound inside a working week. The tape is the problem — price has just confirmed a death cross (Mar 27, 2026), sits 24% below the 200-day average, has surrendered 45% of its September all-time high, and is parked within 3% of the 52-week low with RSI deeply oversold; everything an analyst wants to do in this stock is fightable, but only against a clearly negative trend regime.

Price data trades in HKD on HKEX; this section reports figures in USD at the peg. Horizon's underlying financials are denominated in CNY.

Portfolio Implementation Verdict

Price Snapshot

Beta is not reported in this panel: with only ~19 months of listing history spanning a parabolic IPO run and a March 2026 death cross, a CAPM beta against any local benchmark would be unstable and uninformative.

Price + 50/200 SMA — Full Listing History

The chart tells one story in two acts: a parabolic five-week run from January to mid-March 2025 that took the stock from $0.47 to $1.17 (+148%), a fast 50% retrace into April, then a second leg up to the September peak at $1.45 — followed by a clean six-month topping pattern and now a death cross on rising downside conviction. The trend regime is down.

Relative Performance Since IPO

Sector ETF and broad-market benchmark series were not staged for this listing in the underlying data set, so a relative-strength overlay is unavailable. Read the chart in absolute terms: the stock is still 57% above the IPO price but has surrendered 53% of the September peak. The post-peak structure (lower highs in November, January, and February) is the dominant feature.

Momentum — RSI(14) and MACD Histogram

Momentum says the same thing the price chart says: lower highs on every push. RSI peaked at 86 in February 2025, 79 in September 2025, 60 in January 2026 — each rally has been weaker than the last. The current RSI of 31.7 is technically oversold (a tradable mean-reversion setup for a quick bounce), but the MACD histogram has crossed back negative after a one-month attempt to recover, so any near-term squeeze is fading rather than building. Near-term bias: down, with bounces to be sold rather than chased.

Volume, Volatility, and Sponsorship

The top three volume spikes of the past year are all down days. That is sponsorship asymmetry — the heaviest hands have been distributing into the rallies, not accumulating into the dips. The August 28 (+14.7%, 4.27x volume) and February 6 (+14.4%, 5.73x) spikes are notable green prints, but neither held above the September peak, and both have since been retraced. This is not the volume signature of a bottom.

Realized volatility is in the lower-half "normal" band at 49.9% (p20=43, p50=53). That's the analytically interesting thing: the stock has fallen 45% from highs without a volatility blowout — orderly distribution, not a panic. Forced sellers or earnings shocks would have shown up in a vol expansion above the p80 band (83%); we are nowhere near that. Translation: the move down has further to run before a volatility-driven capitulation gives a clean reversal signal.

Institutional Liquidity Panel

Roughly 1.1% of the market cap turns over every trading day, and the entire float would change hands roughly 2.4 times over a year at the current rate — extreme for a stock with $10.6B market cap. This is real, institution-grade liquidity, not a thinly-traded recent IPO.

A. Fund-capacity table — for a fund that wants a 5-day execution window, the table below answers "what fund AUM does this stock support at common position weights?"

B. Liquidation runway — how many trading days are required to fully exit an issuer-level position of 0.5% / 1% / 2% of market cap.

C. Execution friction proxy — median 60-day daily price range is 4.1%, well above the 2% comfort line. Translation: even with deep top-of-book liquidity, large parent orders should expect material slippage and benefit from VWAP-style algos rather than block-style takes.

Bottom line on size: at 20% participation, an institutional desk can build or unwind a 1% issuer-level position inside one trading week and a 2% position in roughly three weeks. The stock supports a 5% portfolio weight for funds up to $2.03B at normal participation — comfortably mid-cap-fund territory. At a more conservative 10% participation, the comfortable cap drops to $1.02B AUM at 5% weight, which is still institutional.

Technical Scorecard + Stance

Aggregate technical stance score: −4 of a possible −6 — clearly bearish.

Stance

Bearish, 3–6 month horizon. The tape has just confirmed a death cross with price 24% below the 200-day, top-tick distribution into every rally for eight months, and a 52-week-low test in progress. The MACD/RSI oversold bounce should be sold rather than chased until two things happen together: (a) price reclaims the $0.92 moving-average cluster with the 50-day starting to flatten, and (b) volume on up-days exceeds volume on down-days for at least two consecutive weeks. Below $0.78 (the 52-week and post-IPO low) the next reference is the IPO band at $0.51–0.52 — a 35% air-pocket with no intermediate horizontal support. Bullish invalidation: a clean weekly close above $1.06 (200-day), which would also flip the death cross.

Liquidity is not the constraint. A fund of any plausible size for a HK-listed mid-cap semiconductor name can act here at normal participation. The constraint is timing and structure: the right action is watchlist only, with size built only on a confirmed trend change above $0.92, scaled up above $1.06. Funds already long should treat $0.78 as a hard line and trim into any rally toward $0.92 that fails to extend.